CERO Financials
Cero Therapeutics Holdings Inc - Financial statements & key metrics
Stock Price
$0.04
Market Cap
$844,106
EPS
$-2.67
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
$-1.16M
Operating Income
$-15.30M
Net Income
$-7.73M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$6.21M
Total Liabilities
$8.10M
Shareholders Equity
$-1.89M
Cash & Equivalents
$3.33M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-5.79M
CapEx
$1
Free Cash Flow
$-5.79M
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CERO revenue?
View CERO's income statement for detailed revenue data.
Is CERO profitable?
CERO reported a loss of $7.73M in the most recent quarter.
What is CERO market cap?
CERO has a market capitalization of $844,106, making it a small-cap stock.
Does CERO have debt?
View CERO's balance sheet for debt information.
What is CERO cash flow?
CERO's most recent quarterly free cash flow was $-5.79M.